Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
Q1 2026 vs. Q4 2025
How the institutions holding Editas Medicine, Inc. changed between Q4 2025 and Q1 2026.
All holders in Q1 2026All holders in Q4 2025
| Measure | Q4 2025 | Of which not filed for Q1 2026 | Q1 2026 | Change |
|---|---|---|---|---|
| Holders | 197 | 3 | 208 | +14 |
| Shares | 49.9M | 8.22M | 51.8M | +10.1M (+24.2%) |
| Value | $102.5M | $16.8M | $127.5M | +$41.9M (+48.9%) |
3 institutions that held it in Q4 2025 haven't filed for Q1 2026 yet. Not filing isn't selling, so the changes leave them out.
New holders (38)
Institutions that held Editas Medicine, Inc. at the end of Q1 2026 but not at the end of Q4 2025.
Sold out (24)
Institutions that held Editas Medicine, Inc. at the end of Q4 2025 and filed for Q1 2026 without it.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Two Sigma Advisers, LP | 1,224,100 | $2.51M |
| Dimensional Fund Advisors LP | 335,479 | $687.7K |
| Millennium Management LLC | 162,330 | $332.8K |
| Graham Capital Management, L.P. | 139,904 | $286.8K |
| Walleye Capital LLC | 119,397 | $244.8K |
| Quadrature Capital Ltd | 107,376 | $220.1K |
| Squarepoint Ops LLC | 91,846 | $188.3K |
| EntryPoint Capital, LLC | 84,554 | $173.3K |
| Texas Yale Capital Corp. | 70,000 | $143.5K |
| Virtu Financial LLC | 43,228 | $89.0K |
| HCR Wealth Advisors | 17,000 | $34.9K |
| StoneX Group Inc. | 15,855 | $32.5K |
| Patriot Financial Group Insurance Agency, LLC | 15,000 | $30.8K |
| Engineers Gate Manager LP | 13,572 | $27.8K |
| Neuberger Berman Group LLC | 10,908 | $22.4K |
| Franklin Resources Inc | 10,702 | $21.9K |
| Amalgamated Bank | 2,848 | $6.00K |
| Quattro Advisors LLC | 1,578 | $3.23K |
| Strategic Advocates LLC | 1,077 | $2.20K |
| Daiwa Securities Group Inc. | 277 | $1.00K |
| Raelipskie Partnership | 200 | $410 |
| Curio Wealth, LLC | 77 | $170 |
| SageView Advisory Group, LLC | 14 | $29 |
| Quintet Private Bank (Europe) S.A. | 6 | $12 |
Not filed for Q1 2026 yet (3)
Institutions that held Editas Medicine, Inc. at the end of Q4 2025 and haven't filed a 13F for Q1 2026. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q4 2025 | Value, Q4 2025 |
|---|---|---|
| Vanguard Group Inc | 8,208,068 | $16.8M |
| CIBC Private Wealth Group, LLC | 7,300 | $15.0K |
| Comerica Bank | 54 | $111 |